“Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?

Yvonne Sleiman (1) , Alain Lacampagne (1) , Albano C Meli (1)

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]

The regulation of intracellular calcium (Ca 2+ ) homeostasis is fundamental to maintain normal functions in many cell types. The ryanodine receptor (RyR), the largest intracellular calcium release channel located on the sarco/endoplasmic reticulum (SR/ER), plays a key role in the intracellular Ca 2+ handling. Abnormal type 2 ryanodine receptor (RyR2) function, associated to mutations (ryanopathies) or pathological remodeling, has been reported, not only in cardiac diseases, but also in neuronal and pancreatic disorders. While animal models and in vitro studies provided valuable contributions to our knowledge on RyR2 dysfunctions, the human cell models derived from patients’ cells offer new hope for improving our understanding of human clinical diseases and enrich the development of great medical advances. We here discuss the current knowledge on RyR2 dysfunctions associated with mutations and post-translational remodeling. We then reviewed the novel human cellular technologies allowing the correlation of patient’s genome with their cellular environment and providing approaches for personalized RyR-targeted therapeutics.

Domaines: Sciences du Vivant [q-bio]

Yvonne Sleiman, Alain Lacampagne, Albano C Meli. “Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?. Cell Death and Disease, 2021, 12 (11), ⟨10.1038/s41419-021-04337-9⟩. ⟨hal-03412490⟩